NIH Licensing Would Benefit from Free-Market Provisions

Journal of Law, Medicine and Ethics 51 (S2):24-27 (2023)
  Copy   BIBTEX

Abstract

Government encouragement of free markets is a highly effective means of fostering pharmaceutical innovation; the NIH, by including “free-market provisions” in its licensing agreements that discourage anti-competitive and research-impeding behavior, can do a great deal to support this goal even without legislative overhaul.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,438

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

A Biotechnology Patent Pool: An Idea Whose Time Has Come?David B. Resnik - 2003 - Journal of Philosophy, Science and Law 3:1-22.
The Government Strategies on Firm's in Merging and Licensing.Chang-Ying Li & Juan Song - 2006 - Nankai University (Philosophy and Social Sciences) 1:125-132.
Free choice, modals, and imperatives.Maria Aloni - 2007 - Natural Language Semantics 15 (1):65-94.
The free market model versus government: A reply to Nozick.John T. Sanders - 1977 - Journal of Libertarian Studies 1 (1):35-44.
Free Market: The History of an Idea.Ian Kumekawa - 2023 - History of European Ideas 49 (2):488-489.

Analytics

Added to PP
2024-03-05

Downloads
5 (#1,522,914)

6 months
5 (#632,346)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references